Navigation Links
Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders' Equity Deficiency
Date:5/15/2008

AMEX's $6 million stockholders' equity threshold required for continued listing under AMEX Rule 1003(a)(iii). This notification was triggered by the decline of Signalife's market capitalization to less than $50 million, which previously exempted Signalife from meeting the minimum stockholders' equity requirement. In response to the letter, Signalife submitted to AMEX for its review and acceptance a plan to bring the company into compliance with the aforesaid stockholders' equity requirement. On March 20, 2008, AMEX notified Signalife that it accepted the company's plan of compliance and granted the company an extension until May 7, 2009 to regain compliance with the aforesaid stockholders' equity requirement. On May 14, 2008, Signalife received a second deficiency letter from the American Stock Exchange ("AMEX") pursuant to which it advised that Signalife would also need to comply with AMEX's $4 million stockholders' equity threshold required for continued listing under AMEX Rule 1003(a)(ii). In that letter, AMEX advised Signalife that should it desire to do so, the company could supplement its pending plan of compliance to address this new deficiency. Signalife believes that its pending plan of compliance will have equal applicability to the new deficiency cited, and has notified AMEX that it will be supplementing its pending plan of compliance to address this new issue. No guarantee can be given that AMEX will accept the plan as supplemented or that Signalife will be able to so increase its stockholders' equity to the $4 million threshold within the period stipulated by AMEX, either of which would lead to a delisting of Signalife's common shares from the AMEX market.

About Signalife

Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices, therapies and/or technologies t
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
2. Signalife Announces Webcast
3. AMEX Notifies Signalife That It Has Accepted Signalifes Plan of Compliance
4. Signalife Sees Accretive Purchase and Financial Commitments
5. Signalife Wins Second Frost & Sullivan Technology Award
6. Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
7. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement
8. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
9. U.S. Patent 7,299,083 Awarded to Signalife
10. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
11. Signalife Continues to Procure Purchase Orders, Revenues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Women in the West ... an additional family planning option. Sayana® Press has ... all levels of the health system and in ... widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with the ... the first of four African countries expected to ...
(Date:7/10/2014)... 10, 2014 Product and process ... low abundance and are often “lost in the ... , Join presenters Dr. Rowel Tobias, Senior Scientist, ... Anders, Head of Quality at Nanotherapeutics, Inc., to ... can speed detection and quantitation while achieving the ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Deep ... Century Medicine Forum on ‘Commercialising Longevity Research’ and ... entrepreneurs to the London Bioscience Innovation Center for ... Foundation and Aging Analytics Ltd. The meeting highlighted ... in translational research for age-related disease, as well ...
(Date:7/10/2014)... July 10, 2014 Understanding the need ... cell lines, and the gap that currently exists in ... expand its industry-leading portfolio of validated ion channel and ... channel-expressing cell lines, as ion channels control many critical ... this activity creates the potential to treat a variety ...
Breaking Biology Technology:Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3
... April 24 Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma" or, ... financial results for the nine month period ended February 28, 2009.Financial ... Sales revenue increased to US $2,715,702 for the ... corresponding period ended February 29, 2008. , ...
... 24 Dr. Susan Weinschenk is Chief of ... global leader of user experience design services. Dr. Weinschenk recently ... : What makes them click? ... decision makers immediately took note. Accolades about her book and ...
... -Testimony To Legislature Calls For Rejection Of Legislation That ... 24 In testimony to the Legislature and a ... largest biotechnology association warned that a bill under consideration ... and onerous regulatory environment for biotechnology growth and development ...
Cached Biology Technology:Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009 2Dr. Susan Weinschenk, Chief of Technical Staff and Services, Speaks on Neuro Web Design at 'Persuasive Technologies 2009 Conference' and 'Voices That Matter Web Design Conference' 2Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences 2
(Date:7/10/2014)... Society (ACS) announced today that Courtney Aldrich, Ph.D., ... Infectious Diseases as editor-in-chief. With the first ... pioneering journal will meet a growing demand for ... research. , "Our vision is to develop a ... on the basic science that advances the field ...
(Date:7/10/2014)... satellite spotted smoke over the U.S. Mid-West from ... , At 1200 UTC (8 a.m. EDT) on ... the brownish-colored haze created by forest fires in ... into South Dakota. This image was created by ... Flight Center, Greenbelt, Md. , According to ...
(Date:7/10/2014)... National Cancer Research Centre (CNIO) Macromolecular Crystallography Group ... protein called BuD to DNA in order to ... the researcher who led the study, says the ... the instructions contained in the genome to treat ... study is published in the journal Acta ...
Breaking Biology News(10 mins):ACS Infectious Diseases: Unique chemistry journal names editor 2CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2
... AMES, Iowa Venture capitalist Vinod Khosla told last ... why he believes fuel blends containing 85 percent ethanol ... who last year told The New York Times ... companies developing ethanol production technologies ticked off several ...
... greatly increases the risk of heart attack and stroke ... the heart and blood vessels, researchers at the Saint Louis ... could lead to new therapies to treat or prevent heart ... States as well as answer key questions about other ...
... a prestigious American science journal proves that mercury atmospheric ... as three years. Biologists from the University of Alberta ... and carrying out the experiment. The study concludes ... other industrial activities were to be cut immediately, the ...
Cached Biology News:Iowa State University conference examines developing bioeconomy 2Research explains link between cholesterol and heart disease 2
... The epitope specific for Nabeta2 ... other known proteins.,SPECIES REACTIVITIES: ... on human because the immunogen ... residues). Reactivity with other species ...
Goat polyclonal to JIK ( Abpromise for all tested applications). Antigen: Synthetic peptide: HKKDHVFIRDEAGHGD, corresponding to amino acids 396-411 of Human JIK. Entrez Gene ID: 51347 Swi...
Anti-LC3 Polyclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...
...
Biology Products: